Ligand Pharmaceuticals/ US53220K5048 /
| 10/06/2024 21:59:59 | Chg. -1.79 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 79.72USD | -2.19% | 13,178 Turnover: 1.04 mill. |
-Bid Size: - | -Ask Size: - | 79.98 | 77.15 |
GlobeNewswire
14/05
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
GlobeNewswire
06/05
The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire
28/03
Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development
GlobeNewswire
08/03
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire
11/01
Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel End...
GlobeNewswire
12/12/2023
Sermonix Pharmaceuticals Shares Pharmacokinetic and Baseline Genomic Clinical Data Tied to ELAINE La...
GlobeNewswire
12/12/2023
Sermonix Pharmaceuticals Shares Results of Third Survey on ESR1 and Metastatic Breast Cancer Patient...
GlobeNewswire
11/12/2023
Sermonix Pharmaceuticals Announces Publication of ELAINE-1 and ELAINE-2 Trial Results in Annals of O...
GlobeNewswire
01/12/2023
Palvella Therapeutics and Ligand Pharmaceuticals Expand Strategic Partnership to Accelerate Phase 3 ...
GlobeNewswire
28/11/2023
Sermonix Pharmaceuticals Announces Five Abstracts Accepted for Presentation at 2023 San Antonio Brea...
GlobeNewswire
06/11/2023
Sermonix Pharmaceuticals Announces JCO Precision Oncology Publication of Case Report on a Complete R...
GlobeNewswire
03/11/2023
Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
GlobeNewswire
18/10/2023
Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest i...
GlobeNewswire
02/10/2023
Sermonix Pharmaceuticals Shares Results of EQUALS 2 Survey on Vaginal and Sexual Health in Patients ...
GlobeNewswire
02/10/2023
Sermonix Pharmaceuticals Announces Results of ELAINE-1 Exploratory Analysis Evaluating Effect of Pat...
GlobeNewswire
05/09/2023
Sermonix Pharmaceuticals Shares Encore ELAINE-2 Poster Presentation at 2023 Metastatic Breast Cancer...
GlobeNewswire
24/03/2022
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Emclaire Fi...
GlobeNewswire
22/02/2022
Novan Reports Full Year 2021 Financial Results and Provides Corporate Update
GlobeNewswire
18/02/2022
Organovo Welcomes New Sr. Vice President of Strategy and Business Development
GlobeNewswire
16/02/2022
AI Therapeutics Appoints Brigette Roberts, M.D., as Chief Executive Officer
